Director, Market Access APAC — Oncology Payer Strategy

Telix Pharmaceuticals Limited; Australia; Hybrid; AUD 180,000 - 230,000; Full time

Job summary

Telix Pharmaceuticals Limited is seeking a Director, Market Access APAC to lead market access strategy and execution across Asia Pacific, including Japan, Australia, China and Korea, with up to 50% travel. You will shape pricing and reimbursement, engage payers, and guide cross-functional teams to optimize access for Telix products.

The role requires a bachelor’s degree and ~8 years in payor/provider relations within pharma, with strong knowledge of US healthcare dynamics and global pricing

Qualifications

• Bachelor’s degree required; life sciences degree preferred.
• Minimum of 8 years of experience in payor/provider relations within the pharmaceutical sector; medical device may be considered.
• Proficient understanding of global healthcare dynamics and pharmaceutical value drivers.

Responsibilities

• Define and develop market access strategies for new products in Asia Pacific.
• Navigate regulatory, pricing, and reimbursement to ensure timely access.
• Lead pricing research, payer engagement, and commercial contracting aligned with brand objectives.
• Collaborate with division and product leads on strategic direction across the Telix portfolio.
• Provide leadership on private and public sector coverages and patient access.
• Produce market access forecasting for Asia Pacific markets.

Skills

Market access

Pricing strategy

Payer engagement

Strategic leadership

Cross-functional collaboration

Education

Bachelor’s degree

Job description

Telix Pharmaceuticals Limited is seeking a Director, Market Access APAC to lead market access strategy and execution across Asia Pacific, including Japan, Australia, China and Korea, with up to 50% travel. You will shape pricing and reimbursement, engage payers, and guide cross-functional teams to optimize access for Telix products.

The role requires a bachelor’s degree and ~8 years in payor/provider relations within pharma, with strong knowledge of US healthcare dynamics and global pricing